BMEA vs CAH
Biomea Fusion Inc (BMEA) versus Cardinal Health Inc (CAH) — a side-by-side from cached financials, not a winner call.
Biomea Fusion Inc (BMEA) is a biotechnology company listed on US.
Cardinal Health Inc (CAH) is a medical distribution company listed on NYSE.
BMEA does not have a complete income-statement cache yet.
Latest reported CAH revenue for 2025-06-30 was $222.58B. Net income was $1.57B. Revenue was down 1.9% from 2024-06-30 to 2025-06-30. CAH currently screens at market cap $53.00B and trailing P/E 34.6.
BMEA currently screens at market cap $94.7M. CAH currently screens at market cap $53.00B and trailing P/E 34.6.
Not investment advice. Open the BMEA and CAH stock pages for the full models.
Not investment advice.